about
Expression of mutant Ets protein at the neuromuscular synapse causes alterations in morphology and gene expressionStaufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease ModifierStaufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I.PAK1 and CtBP1 Regulate the Coupling of Neuronal Activity to Muscle Chromatin and Gene Expression.Staufen1 impairs stress granule formation in skeletal muscle cells from myotonic dystrophy type 1 patients.Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events.Postsynaptic chromatin is under neural control at the neuromuscular junction.Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog.Maintenance of CCL5 mRNA stores by post-effector and memory CD8 T cells is dependent on transcription and is coupled to increased mRNA stability.The RNA-binding protein Staufen1 impairs myogenic differentiation via a c-myc-dependent mechanism.Thrombin downregulates muscle acetylcholine receptors via an IP3 signaling pathway by activating its G-protein-coupled protease-activated receptor-1.Thrombin reduces MuSK and acetylcholine receptor expression along with neuromuscular contact size in vitro.MUSK, a new target for mutations causing congenital myasthenic syndrome.[Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene].Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin-NFAT signaling in skeletal muscle of DM1 mice.Towards the molecular elucidation of congenital myasthenic syndromes: identification of mutations in MuSKExpression of Pannexin 1 and Pannexin 3 during skeletal muscle development, regeneration, and Duchenne muscular dystrophyPharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse musclesOverexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features
P50
Q34196106-7E62D612-D0A5-4B39-97F3-8CFC4ABD5175Q35908266-E9599233-D852-4F1A-99AF-3AAC7A12DBECQ36151477-5E38258F-8013-497A-A523-BEC581E4C015Q36289547-61E53AE4-DBED-4DAD-9C7F-DDF4847C0219Q36944554-369EA77B-08C8-48C7-A281-10DF5C3D3A79Q37648694-8E0B6066-086A-4CC6-B0E1-697F22A967FCQ38304650-1B87E072-23AC-4253-A2DD-AFE1EC4F0695Q38860146-F9CCA447-230E-4C7B-8F1A-84351EC4F268Q42835371-3D153596-4E18-4949-9D17-E44028F145FDQ43004450-0DC3783F-E779-4018-9A73-3301B8A07A1CQ44453982-440B2056-33C9-455F-A54F-7FEE20B8FBFDQ44847922-1CF178AC-EC03-4140-990D-D06B2917C409Q45116927-6BBB3AA6-8CC3-440C-ABAB-DE3B7FE03B95Q46662240-B3B900DD-63B1-44DA-8D54-93F95E3443DCQ50755664-30ACC688-72BB-4FF3-B9A9-C6AF5B592276Q60474541-5F34BA35-B090-47DB-84C7-D49D8CA59A18Q88622649-A7811EFB-0E3D-4835-A5A2-146B17A4078AQ89457298-B4668914-ECF6-4329-BC34-7DEDA06AA073Q96172154-AA78F55F-D702-4A62-B854-9E3946C27119
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Aymeric Ravel-Chapuis
@ast
Aymeric Ravel-Chapuis
@de
Aymeric Ravel-Chapuis
@en
Aymeric Ravel-Chapuis
@es
Aymeric Ravel-Chapuis
@fr
Aymeric Ravel-Chapuis
@nl
Aymeric Ravel-Chapuis
@sl
type
label
Aymeric Ravel-Chapuis
@ast
Aymeric Ravel-Chapuis
@de
Aymeric Ravel-Chapuis
@en
Aymeric Ravel-Chapuis
@es
Aymeric Ravel-Chapuis
@fr
Aymeric Ravel-Chapuis
@nl
Aymeric Ravel-Chapuis
@sl
prefLabel
Aymeric Ravel-Chapuis
@ast
Aymeric Ravel-Chapuis
@de
Aymeric Ravel-Chapuis
@en
Aymeric Ravel-Chapuis
@es
Aymeric Ravel-Chapuis
@fr
Aymeric Ravel-Chapuis
@nl
Aymeric Ravel-Chapuis
@sl
P1053
D-2296-2016
P106
P1153
6506863285
P1960
pXuhIAkAAAAJ
P21
P2798
P31
P3829
P3835
aymeric-ravel-chapuis
P496
0000-0002-6965-7372
P569
2000-01-01T00:00:00Z